Sun Pharma Shares Gains as Company Set to Acquire 38% Stake in EzeRx Health Tech

Sun Pharma Shares Gains as Company Set to Acquire 38% Stake in EzeRx Health Tech
Sun Pharma Shares Gains as Company Set to Acquire 38% Stake in EzeRx Health Tech

Sun Pharma Shares industries rose 1% on October 6 after the company reached an agreement to acquire a minority stake in EzeRx Health Tech Pvt Ltd. It had been completed.

JOIN OUR TELEGRAM

The pharma major will acquire a 37.76% stake in EzeRx Health Tech for Rs 28.69 billion, which is expected to be closed by the end of this month, subject to the satisfaction of certain conditions.

EzeRx Health Tech is a company specializing in the manufacturing, marketing and sales of non-invasive diagnostic and additive devices for domestic and international markets.

This investment is in line with the company’s efforts to diversify and strengthen its product portfolio, primarily in the area of ​​non-invasive medical technologies.

Founded on July 3, 2018, his EzeRx Health Tech is a young medical technology company focused on innovative, non-invasive screening solutions used for early detection of primary health parameters. In the last financial year, EzeRx Health Tech reported an operating revenue of Rs 615 crore.

The pharmaceutical company also signed an agreement to acquire an additional 4.04% stake in Agatsa Software Private Ltd. announced.

As of 1:27 pm, shares of Sun Pharmaceutical Industries were trading at Rs 1,129.90 on the NSE, 0.97 per cent higher than the previous closing price.

 

 

ALSO READ – Lupin Receives Tentative USFDA Approval for Tolvaptan Tablets; Shares Gain

Leave a Comment